Pulse Biosciences

3957 Point Eden Way
United States

Tel: 510-906-4600

Show jobs for this employer

About Pulse Biosciences

Pulse Biosciences, Inc, is a bioelectric medicine company pursuing commercial introduction of our proprietary CellFX™ System harnessing the distinctive advantages of our patented Nano-Pulse Stimulation™ (NPS™) technology. NPS technology delivers nano-second pulses of high amplitude electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue. The cell-specific effects of NPS technology have been validated in a series of ongoing clinical trials, and with a growing patent portfolio, Pulse Biosciences is building a rich pipeline of transformative commercial applications.

Pulse Biosciences is preparing to launch the CellFX System in 2019 as a multi-application platform designed to address a broad range of dermatologic conditions. The initial commercial use will be in the clearance of common skin lesions, including sebaceous hyperplasia (SH) and seborrheic keratosis (SK)  - two prevalent and difficult-to-treat benign skin conditions that share high demand among patients and practitioners for improved and durable aesthetic outcomes that lead to greater overall satisfaction.

Stock Symbol: PLSE


70 articles with Pulse Biosciences